Rockefeller joins Pfizer’s Global Centers For Therapeutic Innovation
Wednesday, January 26, 2011 - 15:10
in Psychology & Sociology
A new partnership will mimic a venture capital-funded biotechnology start-up model, whereby Pfizer funds pre-clinical and clinical development programs in return for the opportunity to potentially broaden its pipeline with novel and highly differentiated candidate drugs.
Read the whole article on The Rockefeller University
More from The Rockefeller University
Related
- New nanoparticles could revolutionize therapeutic drug discoveryThu, 25 Jun 2009, 10:17:54 EDT
- Pfizer Hemophilia presents new data at the World Federation of Hemophilia 2010 CongressFri, 9 Jul 2010, 1:49:47 EDT
- Many NIH-funded clinical trials go unpublished over 2 years after completionWed, 4 Jan 2012, 5:04:45 EST
- New lung cancer drug shows dramatic results for shrinking tumorsTue, 22 Jun 2010, 14:33:50 EDT
- Tipping points -- the future of the pharmaceutical industryFri, 4 Feb 2011, 11:12:49 EST